Search

Displaying results 5841 - 5850 of 10000 in total
  1. Drug

    Camponotus pennsylvanicus

    go.drugbank.com/drugs/DB14710
    Approved

    Camponotus pennsylvanicus allergenic extract is used in allergenic testing.

  2. Drug

    Eurotium amstelodami

    go.drugbank.com/drugs/DB15526
    Approved

    Eurotium amstelodami allergenic extract is used in allergenic testing.

  3. Drug

    Skim milk

    go.drugbank.com/drugs/DB15546
    Approved

    Skim milk allergenic extract is used in allergenic testing.

    Synonyms: Lac defloratum
  4. Drug

    Field mushroom

    go.drugbank.com/drugs/DB15605
    Approved

    Field mushroom allergenic extract is used in allergenic testing.

  5. Drug

    Milataxel

    go.drugbank.com/drugs/DB12334
    Investigational

    Milataxel has been used in trials studying the treatment of Mesothelioma.

  6. Drug

    Eldelumab

    go.drugbank.com/drugs/DB06116
    Investigational

    MDX-1100, a fully human antibody that targets IP10 (also known as CXCL10), a chemokine expressed in association with multiple inflammatory disease indications, such as rheumatoid arthritis, inflammatory

  7. Drug

    (+)-Mefloquine

    go.drugbank.com/drugs/DB05636
    Investigational

    (+)-Mefloquine was under investigation in clinical trial NCT00931697 (Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine) to

  8. Drug

    Ronacaleret

    go.drugbank.com/drugs/DB05255
    Investigational

    Ronacaleret is a calcium-sensing receptor antagonist.

  9. Drug

    Afimetoran

    go.drugbank.com/drugs/DB16580
    Investigational

    [L32018, L32023] It is also is under investigation in clinical trial NCT04269356 (Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male … Afimetoran is an immunomodulator and an antagonist of toll-like receptors 7 and 8.

  10. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).